Senior Manager, Market Access & Corporate Affairs

Overview

The Senior Manager Market Access & Corporate Affairs Germany will manage Pricing & Market Access (PMA) for AYVAKYT (avapritinib) in indolent and advanced systemic mastocytosis and plan and execute communication & PR and Patient Affairs & Governmental Affairs activities. The role aims to identify the needs of patients, healthcare providers and payers in Germany, address challenges and opportunities to maximize access, communicate with stakeholders and contribute to BPMs success. Analyze and assess market access insights, and develop strategies and solutions for implementation.

What will you do?

• Support with HTA (AMNOG) assessment procedure including written statement and oral hearing;
• Develop materials for payer engagement initiatives;
• Support price negotiations with pricing analysis, pricing intelligence and HEOR initiatives;
• Manage regional and local hurdles and opportunities with Avapritinib and support field teams;
• Develop and execute the PR/communication plan aligned with brand strategy;
• Analyze and assess governmental regulations on national and local level with impact for BPM and develop recommendations to strengthen BPM business;
• Engage with patient organizations and present BPM as partner in systemic mastocytosis.

Minimum qualifications

• Academic education and experience from similar positions (life science, economics, media)
• Minimum of 5+ years’ experience in pharmaceutical/biotechnology field
• Strong knowledge of Market Access and HTA/Payer requirements, standards and processes, including experience with national and regional authorities, including sick funds and other payers
• Experience with communications and PR initiatives
• Experience to manage complex projects and collaborate with multi-disciplinary teams
• Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

Additional qualifications

• Ability to lead PMA initiatives and work as part of a team under uncertainty with a “can do” attitude
• Ability to prioritize and drive for results with an emphasis on quality.
• Ability to analyze diverse sets of complex information and distill into recommended strategy
• Fluency in German and English, both oral and written
• Effective communication skills at all levels both internally and externally
• In-depth understanding of health insurance systems such as reimbursement pathways, HTA and contracting opportunities

About Blueprint Medicines

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach targets root causes of disease, leveraging deep scientific knowledge and drug discovery expertise across multiple modalities. The company has a proven track record with two approved medicines and is positioned to scale impact through its broad pipeline. As of July 17th, 2025 Blueprint Medicines is a Sanofi company.

Blueflex

Blueflex is our operating model which optimizes culture, productivity, and flexibility by combining in-person work with added flexibility, enabling a mix of in-office and remote work.

#J-18808-Ljbffr